NO992968L - Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser - Google Patents

Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser

Info

Publication number
NO992968L
NO992968L NO992968A NO992968A NO992968L NO 992968 L NO992968 L NO 992968L NO 992968 A NO992968 A NO 992968A NO 992968 A NO992968 A NO 992968A NO 992968 L NO992968 L NO 992968L
Authority
NO
Norway
Prior art keywords
piperazinyl
preparation
new
benzoic acid
acid derivatives
Prior art date
Application number
NO992968A
Other languages
English (en)
Other versions
NO312896B1 (no
NO992968D0 (no
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Messangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO992968D0 publication Critical patent/NO992968D0/no
Publication of NO992968L publication Critical patent/NO992968L/no
Publication of NO312896B1 publication Critical patent/NO312896B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NO19992968A 1996-12-18 1999-06-17 Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt farmasöytiske preparater som omfatter dem NO312896B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (3)

Publication Number Publication Date
NO992968D0 NO992968D0 (no) 1999-06-17
NO992968L true NO992968L (no) 1999-08-17
NO312896B1 NO312896B1 (no) 2002-07-15

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992968A NO312896B1 (no) 1996-12-18 1999-06-17 Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt farmasöytiske preparater som omfatter dem

Country Status (26)

Country Link
US (1) US6281215B1 (no)
EP (1) EP0937054B1 (no)
JP (1) JP2001506645A (no)
KR (1) KR20000069544A (no)
CN (1) CN1073102C (no)
AR (1) AR013889A1 (no)
AT (1) ATE218558T1 (no)
AU (1) AU726640B2 (no)
BR (1) BR9713587A (no)
CA (1) CA2275346A1 (no)
CZ (1) CZ218999A3 (no)
DE (1) DE69713128T2 (no)
DK (1) DK0937054T3 (no)
ES (1) ES2178039T3 (no)
FR (1) FR2757158B1 (no)
HU (1) HUP0000586A3 (no)
ID (1) ID23671A (no)
NO (1) NO312896B1 (no)
PL (1) PL334187A1 (no)
PT (1) PT937054E (no)
RU (1) RU2178786C2 (no)
SK (1) SK282841B6 (no)
TR (1) TR199901367T2 (no)
UA (1) UA56206C2 (no)
WO (1) WO1998027078A1 (no)
ZA (1) ZA9711329B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same

Also Published As

Publication number Publication date
HUP0000586A2 (hu) 2001-04-28
AU726640B2 (en) 2000-11-16
CN1245494A (zh) 2000-02-23
JP2001506645A (ja) 2001-05-22
ATE218558T1 (de) 2002-06-15
SK78599A3 (en) 2000-03-13
DE69713128T2 (de) 2003-03-20
TR199901367T2 (xx) 1999-10-21
DE69713128D1 (de) 2002-07-11
WO1998027078A1 (en) 1998-06-25
SK282841B6 (sk) 2002-12-03
FR2757158B1 (fr) 1999-04-02
NO312896B1 (no) 2002-07-15
EP0937054B1 (en) 2002-06-05
NO992968D0 (no) 1999-06-17
AR013889A1 (es) 2001-01-31
CA2275346A1 (en) 1998-06-25
UA56206C2 (uk) 2003-05-15
BR9713587A (pt) 2000-04-04
PT937054E (pt) 2002-11-29
FR2757158A1 (fr) 1998-06-19
KR20000069544A (ko) 2000-11-25
EP0937054A1 (en) 1999-08-25
ID23671A (id) 2000-05-11
DK0937054T3 (da) 2002-09-16
CN1073102C (zh) 2001-10-17
CZ218999A3 (cs) 1999-09-15
AU5758298A (en) 1998-07-15
ZA9711329B (en) 1998-06-24
US6281215B1 (en) 2001-08-28
RU2178786C2 (ru) 2002-01-27
ES2178039T3 (es) 2002-12-16
HUP0000586A3 (en) 2002-10-28
PL334187A1 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
NO991761D0 (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO308660B1 (no) Nye 2,3-diketopiperazin-derivater eller deres salter, anvendelse derav og farmasøytisk preparat inneholdende slike
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20013478D0 (no) Nye aralkylaminer av spirofluorpyridiner som er nyttige i terapi
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
NO984717L (no) Nye hydroksamsyre-derivater, deres fremstilling og anvendelse
PT908458E (pt) Piridilmetilpiperazina substituida e derivados piperidina, sua preparacao e utilizacao para tratar as doencas do sistema nervoso central (cns)
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO984714L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO951147D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
NO984713D0 (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO994426D0 (no) Nye karboksylsyrederivater, deres fremstilling og anvendelse ved behandling av kreft
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO992968D0 (no) Nye 4-(piperazinyl)benzosyrederivater, fremgangsmÕte for fremstilling derav, samt deres farmas°ytiske anvendelser
NO980929D0 (no) Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse
NO20014632D0 (no) Nye morfolinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende de nevnte derivater
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO983829L (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
DK0452850T3 (da) 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO963129D0 (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO307421B1 (no) Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter